GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform
May 30, 2017 07:00 ET
|
GeneCentric Therapeutics, Inc.
DURHAM, N.C., May 30, 2017 (GLOBE NEWSWIRE) -- GeneCentric Therapeutics, Inc., a precision medicine company dedicated to accelerating drug development by redefining the advanced classification of...